AIAI

AI Innovation Meets Content Creation: AIAI Generator Shatters Limits with Free Tool Suite; Upgraded Plans Available

Retrieved on: 
Tuesday, May 30, 2023

SACRAMENTO, Calif., May 30, 2023 /PRNewswire/ -- Artificial Intelligence specialists, AIAI Generator, announced the official launch of its revolutionary content creation suite.

Key Points: 
  • SACRAMENTO, Calif., May 30, 2023 /PRNewswire/ -- Artificial Intelligence specialists, AIAI Generator, announced the official launch of its revolutionary content creation suite.
  • The platform harnesses AI to offer compelling, SEO-friendly content that not only engages audiences but also enhances online visibility.
  • "AIAI Generator is designed to cater to the myriad needs of the online content space," said the company.
  • AI is rapidly transforming the landscape of various sectors, and AIAI Generator has positioned itself in the vanguard of this content creation revolution.

NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT

Retrieved on: 
Tuesday, May 16, 2023

Through newly developed algorithms, NetraGPT builds upon the powerful hypotheses generated from the Company's proprietary Good Clinical Practice (GCP) validated AI/ ML system, NetraAI.

Key Points: 
  • Through newly developed algorithms, NetraGPT builds upon the powerful hypotheses generated from the Company's proprietary Good Clinical Practice (GCP) validated AI/ ML system, NetraAI.
  • NetraGPT now revolutionizes the power of NetraAI whereby the NetraAI output is fed into generative pre-trained (GPT) models utilizing Large Language Model (LLM) APIs.
  • "NetraGPT is a critical and differentiated offering that places NetraMark at the forefront of AI innovation for clinical trial de-risking in the Pharmaceutical Industry.
  • NetraAI is built to explain what it finds and this property makes our technology an optimal partner for ChatGPT.

INTRODUCING NETRAMARK - A PHARMA AI COMPANY

Retrieved on: 
Monday, January 30, 2023

TORONTO, Jan. 30, 2023 /PRNewswire/ - (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF) -Today we would like to announce that Nurosene Health Inc. (the "Company" or "NetraMark") will change our official corporate name to NetraMark Holdings Inc.

Key Points: 
  • TORONTO, Jan. 30, 2023 /PRNewswire/ - (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF) -Today we would like to announce that Nurosene Health Inc. (the "Company" or "NetraMark") will change our official corporate name to NetraMark Holdings Inc.
  • "It is our intent to be a leader in the development of Artificial Intelligence (AI) / Machine Learning (ML) solutions targeted at the pharmaceutical industry.
  • This is an important time for AI and there is a clear opportunity in the pharmaceutical industry, as outlined below".
  • There is no change in the share capital of the Company, and shareholders are not required to exchange their existing share certificates for new certificates.

CSE Bulletin: Name and Symbol Change - Nurosene Health Inc. (MEND)

Retrieved on: 
Monday, January 30, 2023

Toronto, Ontario--(Newsfile Corp. - le 30 janvier/January 2023) - Nurosene Health Inc. (MEND) has announced a name and symbol change to NetraMark Holdings Inc. (AIAI).

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - le 30 janvier/January 2023) - Nurosene Health Inc. (MEND) has announced a name and symbol change to NetraMark Holdings Inc. (AIAI).
  • Shares will begin trading under the new name and symbol and with a new CUSIP number on February 1, 2023.
  • Nurosene Health Inc. (MEND) a annoncé un changement de nom et de symbole pour NetraMark Holdings Inc. (AIAI).
  • Les actions commenceront à être négociées sous le nouveau nom et le nouveau symbole et avec un nouveau numéro CUSIP le 1 février 2023.